Higher body mass index (BMI) is associated with reduced glucocorticoid inhibition of inflammatory cytokine production following acute psychosocial stress in men

Psychoneuroendocrinology

Volumn 33, Issue 8, 2008, Pages 1102-1110

  Wirtz, Petra H ^a   Ehlert, Ulrike ^a   Emini, Luljeta ^a   Suter, Tobias ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Atherosclerosis; BMI; Glucocorticoid sensitivity; Stress; TNF

Indexed keywords

CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE STRESS; ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CYTOKINE PRODUCTION; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; JOB INTERVIEW; MALE; MENTAL STRESS; MENTAL TASK; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; REST; SALIVA LEVEL; SOCIAL STRESS; STATISTICAL ANALYSIS;

ADULT; AGED; BODY MASS INDEX; CIRCADIAN RHYTHM; CYTOKINES; DOWN-REGULATION; DRUG RESISTANCE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OVERWEIGHT; REST; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 49049091911     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.05.002     Document Type: Article

References (63)

1. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 (1995) 286-290
2. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom. Med. 66 (2004) 411-421
3. Bamberger C.M., Schulte H.M., and Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 17 (1996) 245-261
4. Bhattacharyya M.R., and Steptoe A. Emotional triggers of acute coronary syndromes: strength of evidence, biological processes, and clinical implications. Prog. Cardiovasc. Dis. 49 (2007) 353-365
5. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., and Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 1920-1925
6. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes. Rev. 2 (2001) 73-86
7. Black P.H. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med. Hypotheses 67 (2006) 879-891
8. Bray G.A. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 89 (2004) 2583-2589
9. Brueckmann M., Bertsch T., Lang S., Sueselbeck T., Wolpert C., Kaden J.J., Jaramillo C., Huhle G., Borggrefe M., and Haase K.K. Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes. Clin. Chem. Lab. Med. 42 (2004) 1132-1139
10. Brunner E.J., Chandola T., and Marmot M.G. Prospective effect of job strain on general and central obesity in the Whitehall II Study. Am. J. Epidemiol. 165 (2007) 828-837
11. Brunner E.J., Marmot M.G., Nanchahal K., Shipley M.J., Stansfeld S.A., Juneja M., and Alberti K.G. Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 40 (1997) 1341-1349
12. Buemann B., Black E., Holst C., Toubro S., Echwald S., Pedersen O., Astrup A., and Sorensen T. The N363S polymorphism of the glucocorticoid receptor and metabolic syndrome factors in men. Obes. Res. 13 (2005) 862-867
13. Burnstein K.L., Bellingham D.L., Jewell C.M., Powell-Oliver F.E., and Cidlowski J.A. Autoregulation of glucocorticoid receptor gene expression. Steroids 56 (1991) 52-58
14. Cawthorn W.P., and Sethi J.K. TNF-alpha and adipocyte biology. FEBS Lett. 582 (2008) 117-131
15. Creely S.J., McTernan P.G., Kusminski C.M., Fisher M., Da Silva N.F., Khanolkar M., Evans M., Harte A.L., and Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E740-E747
16. Di Blasio A.M., van Rossum E.F., Maestrini S., Berselli M.E., Tagliaferri M., Podesta F., Koper J.W., Liuzzi A., and Lamberts S.W. The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin. Endocrinol. (Oxf.) 59 (2003) 68-74
17. Ebrecht M., Buske-Kirschbaum A., Hellhammer D., Kern S., Rohleder N., Walker B., and Kirschbaum C. Tissue specificity of glucocorticoid sensitivity in healthy adults. J. Clin. Endocrinol. Metab. 85 (2000) 3733-3779
18. Elkind M.S., Cheng J., Boden-Albala B., Rundek T., Thomas J., Chen H., Rabbani L.E., and Sacco R.L. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke 33 (2002) 31-37
19. Epel E.E., Moyer A.E., Martin C.D., Macary S., Cummings N., Rodin J., and Rebuffe-Scrive M. Stress-induced cortisol, mood, and fat distribution in men. Obes. Res. 7 (1999) 9-15
20. Esteve E., Villuendas G., Mallolas J., Vendrell J., Lopez-Bermejo A., Rodriguez M., Recasens M., Ricart W., San Millan J.L., Escobar-Morreale H., Richart C., and Fernandez-Real J.M. Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin. Endocrinol. (Oxf.) 65 (2006) 88-91
21. Gaab J., Baumann S., Budnoik A., Gmunder H., Hottinger N., and Ehlert U. Reduced reactivity and enhanced negative feedback sensitivity of the hypothalamus-pituitary-adrenal axis in chronic whiplash-associated disorder. Pain 119 (2005) 219-224
22. Gidron Y., Gilutz H., Berger R., and Huleihel M. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc. Res. 56 (2002) 15-21
23. Gonzalez F., Minium J., Rote N.S., and Kirwan J.P. Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia. Metabolism 55 (2006) 271-276
24. Hardy M.P., Sottas C.M., Ge R., McKittrick C.R., Tamashiro K.L., McEwen B.S., Haider S.G., Markham C.M., Blanchard R.J., Blanchard D.C., and Sakai R.R. Trends of reproductive hormones in male rats during psychosocial stress: role of glucocorticoid metabolism in behavioral dominance. Biol. Reprod. 67 (2002) 1750-1755
25. Hemingway H., and Marmot M. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 318 (1999) 1460-1467
26. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
27. Jee S.H., Sull J.W., Park J., Lee S.Y., Ohrr H., Guallar E., and Samet J.M. Body-mass index and mortality in Korean men and women. N. Engl. J. Med. 355 (2006) 779-787
28. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., Kannel W.B., and Vasan R.S. Obesity and the risk of heart failure. N. Engl. J. Med. 347 (2002) 305-313
29. Kirschbaum C., Pirke K.M., and Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 (1993) 76-81
30. Kloiber S., Ising M., Reppermund S., Horstmann S., Dose T., Majer M., Zihl J., Pfister H., Unschuld P.G., Holsboer F., and Lucae S. Overweight and obesity affect treatment response in major depression. Biol. Psychiatry 62 (2007) 321-326
31. Laimer M., Ebenbichler C.F., Kaser S., Sandhofer A., Weiss H., Nehoda H., Aigner F., and Patsch J.R. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 659-662
32. Liuzzo G., Baisucci L.M., Gallimore J.R., Caligiuri G., Buffon A., Rebuzzi A.G., Pepys M.B., and Maseri A. Enhanced inflammatory response in patients with preinfarction unstable angina. J. Am. Coll. Cardiol. 34 (1999) 1696-1703
33. Ljung T., Andersson B., Bengtsson B.A., Bjorntorp P., and Marin P. Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study. Obes. Res. 4 (1996) 277-282
34. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
35. Pai J.K., Pischon T., Ma J., Manson J.E., Hankinson S.E., Joshipura K., Curhan G.C., Rifai N., Cannuscio C.C., Stampfer M.J., and Rimm E.B. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 351 (2004) 2599-2610
36. Pasquali R., Vicennati V., Cacciari M., and Pagotto U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann. N. Y. Acad. Sci. 1083 (2006) 111-128
37. Pasqui A.L., Di Renzo M., Auteri A., and Puccetti L. Cytokines in acute coronary syndromes. Int. J. Cardiol. 105 (2005) 355-356
38. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diab. Care 27 (2004) 813-823
39. Piestrzeniewicz K., Luczak K., Komorowski J., Jankiewicz-Wika J., and Goch J.H. Relation of C-reactive protein to obesity, adipose tissue hormones and cardiovascular risk factors in men treated with early percutaneous intervention in course of acute myocardial infarction. Neuro Endocrinol. Lett. 28 (2007) 427-432
40. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol. 88 (2001) 10K-15K
41. Pober J.S., and Cotran R.S. Immunologic interactions of T lymphocytes with vascular endothelium. Adv. Immunol. 50 (1991) 261-302
42. Pruessner J.C., Kirschbaum C., Meinlschmid G., and Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (2003) 916-931
43. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
44. Rohleder N. Dynamic regulation of glucocorticoid sensitivity of pro-inflammatory cytokine production by psychosocial stress (2003), Cuvillier, Göttingen
45. Rohleder N., Kudielka B.M., Hellhammer D.H., Wolf J.M., and Kirschbaum C. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J. Neuroimmunol. 126 (2002) 69-77
46. Rohleder N., Wolf J.M., and Kirschbaum C. Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress 6 (2003) 207-222
47. Rosmond R., Dallman M.F., and Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 83 (1998) 1853-1859
48. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
49. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
50. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21 (2000) 55-89
51. Steptoe A., Hamer M., and Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 21 (2007) 901-912
52. Steptoe A., Strike P.C., Perkins-Porras L., McEwan J.R., and Whitehead D.L. Acute depressed mood as a trigger of acute coronary syndromes. Biol. Psychiatry 60 (2006) 837-842
53. Strike P.C., Magid K., Whitehead D.L., Brydon L., Bhattacharyya M.R., and Steptoe A. Pathophysiological processes underlying emotional triggering of acute cardiac events. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 4322-4327
54. Strike P.C., and Steptoe A. Psychosocial factors in the development of coronary artery disease. Prog. Cardiovasc. Dis. 46 (2004) 337-347
55. Strike P.C., and Steptoe A. Behavioral and emotional triggers of acute coronary syndromes: a systematic review and critique. Psychosom. Med. 67 (2005) 179-186
56. Vendrell J., Broch M., Vilarrasa N., Molina A., Gomez J.M., Gutierrez C., Simon I., Soler J., and Richart C. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 12 (2004) 962-971
57. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
58. Wirtz P.H., Ehlert U., Emini L., Rudisuli K., Groessbauer S., Gaab J., Elsenbruch S., and von Kanel R. Anticipatory cognitive stress appraisal and the acute procoagulant stress response in men. Psychosom. Med. 68 (2006) 851-858
59. Wirtz P.H., Elsenbruch S., Emini L., Rudisuli K., Groessbauer S., and Ehlert U. Perfectionism and the cortisol response to psychosocial stress in men. Psychosom. Med. 69 (2007) 249-255
60. Wirtz P.H., Kanel R.V., Emini L., Suter T., Fontana A., and Ehlert U. Variations in anticipatory cognitive stress appraisal and differential proinflammatory cytokine expression in response to acute stress. Brain Behav. Immun. 21 (2007) 851-859
61. Wirtz P.H., Von Kanel R., Frey K., Ehlert U., and Fischer J.E. Glucocorticoid sensitivity of circulating monocytes in essential hypertension. Am. J. Hypertens. 17 (2004) 489-494
62. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
63. Yamakawa T., Tanaka S., Yamakawa Y., Kiuchi Y., Isoda F., Kawamoto S., Okuda K., and Sekihara H. Augmented production of tumor necrosis factor-alpha in obese mice. Clin. Immunol. Immunopathol. 75 (1995) 51-56